Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer

World Journal of Surgery

Volumn 30, Issue 6, 2006, Pages 1088-1095

  Benbassat, Carlos A ^a,b   Mechlis Frish, Sara ^a,b   Hirsch, Dania ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

ADULT; AGED; BONE METASTASIS; BRAIN METASTASIS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LONG TERM CARE; LUNG METASTASIS; MALE; MEDICAL RECORD; METASTASIS; MORTALITY; ONCOCYTOMA; PATHOLOGY; PREVALENCE; RETROSPECTIVE STUDY; REVIEW; STATISTICAL SIGNIFICANCE; THYROID CANCER; THYROIDECTOMY; UTERUS;

ADENOMA, OXYPHILIC; BONE NEOPLASMS; BRAIN NEOPLASMS; CARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 33744760236     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-005-0472-4     Document Type: Review

References (23)

1. Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Eng J Med 1998;338:297-306.
2. Mizukami Y, Michigishi T, Nonomura A, et al. Distant metastases in differentiated thyroid carcinoma: a clinical and pathologic study. Hum Pathol 1990;21:283-290.
3. Schlumberger M, Tubiana M, De Vathaire F, et al. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 1986;63:960-967.
4. Ruegemer JJ, Hay ID, Bergstralh EJ, et al. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 1988;67:501-508.
5. Wood WJ, Singletary SE, Hickey RC. Current results of treatment for distant metastatic well-differentiated thyroid carcinoma. Arch Surg 1989;124:1374-1377.
6. Shoup M, Stojadinovic A, Nissan A, et al. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg 2003;197:91-97.
7. Lin JD, Huang MJ, Juang JH, et al. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases. Thyroid 1999;9:1227-1235.
8. Pacini F, Cetani F, Miccoli P, et al. Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World J Surg 1994;18:600-604.
9. Mishra A, Kanta Mishra S, Agarwal A, et al. Metastatic differentiated thyroid carcinoma: clinicopathological profile and outcome in an iodine deficient area. World J Surg 2002;26:153-157.
10. Marocci C, Pacini F, Elisei R, et al. Clinical and biologic behaviour of bone metastases from differentiated thyroid carcinoma. Surgery 1989;106:960-967.
11. Kitamura Y, Shimizu K, Nagahama M, et al. Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab 1999;84:4043-4049.
12. Dinneen SF, Valimaki MJ, Bergstralh EJ, et al. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab 1995;80:2041-2045.
13. Colonna M, Grosclaude P, Remonet L, et al. Incidence of thyroid cancer in adults recorded by French cancer registries. Eur J Cancer 2002;38:1762-1768.
14. Parkin DM, Whelam SI, Ferlay J. Cancer Incidence in Five Continents. IARC Scientific Publication 143, Vol. 7 Lyon, France, International Agency for Research on Cancer, 1997.
15. Mazzaferri EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447-1463.
16. Avram AM, Gielczyk R, Su L, et al. Choroidal and skin metastases from papillary thyroid cancer: case and a review of the literature. J Clin Endocrinol Metab 2004;89:5303-5307.
17. Haq M, Harmer C. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clin Endocrinol 2005;63:87-93.
18. Hay ID, Bergstrahl EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1770 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:1050-1058.
19. Hay ID, Bergstrahl EJ, Grant CS, et al. Impact of surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989. Surgery 1999;126:1173-1181.
20. Pelikan DMV, Lion HL, Hermans J, et al. The role of radioactive iodine in the treatment of advanced differentiated thyroid carcinoma. Clin Endocrinol 1997;47:713-720.
21. Maxon HR, Smith HS. Radioiodine 131 in the diagnosis and treatment of metastatic well-differentiated thyroid cancer. Endocrinol Metab Clin North Am 1990;19:685-717.
22. Schlumberger M, Challeton C, De Vathaire F, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 1996;37:598-605.
23. Casara D, Rubello D, Saladini G, et al. Distant metastases in differentiated thyroid cancer: long-term results of radioiodine treatment and statistical analysis of prognostic factors in 214 patients. Tumori 1991;77:432-426.